Holen Sie sich die Stockscreener-App
0.8958
0.32%
0.0029
Handel nachbörslich:
.89
-0.0058
-0.65%
Hyperfine Inc Aktie (HYPR) Neueste Nachrichten
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line - Quiver Quantitative
Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows - TradingKey
Hyperfine, Inc. Q2 2026: Revenue $3.904M, EPS $(0.09) — 10-Q Summary - TradingView
Portable MRI maker Hyperfine's Q2 revenue rises less than expected - TradingView
Hyperfine, Inc. (HYPR) Q2 FY2026 earnings call transcript - Yahoo Finance
Hyperfine reports Q2 2026 revenue $3.9M, net loss $9.3M, expands international approvals - TradingView
Hyperfine, Inc. (NASDAQ: HYPR) grows Q2 sales but remains unprofitable - Stock Titan
Hyperfine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Hyperfine (Nasdaq: HYPR) grows Q2 2026 revenue 44.8% as cash rises to $43.5M - Stock Titan
HYPR: Q2 2026 delivered robust revenue growth, margin expansion, and accelerated global adoption - TradingView
BRIEF-Hyperfine, Inc. Q2 EPS USD -0.09 - TradingView
Hyperfine, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Earnings To Watch: Hyperfine Inc (HYPR) Q2 2026 -- GF Value Sees 72% Upside - Yahoo Finance
Hyperfine Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Hyperfine, Inc. Revenue Breakdown – NASDAQ:HYPR - TradingView
Hyperfine’s portable MRI system featured in medical journals By Investing.com - Investing.com Canada
Hyperfine Inc. (HYPR) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares SlideEarnings Trend Analysis - dars.gov.et
New Hyperfine Swoop® Portable MRI for Easier and Faster Stroke Visualization - marketscreener.com
HYPR|Hyperfine Inc|Price:0.936|Chg%:+0.008 - TradingKey
Hyperfine Inc (HYPR) Institutional Confidence - TradingKey
Hyperfine Inc (HYPR) Balance Sheet - TradingKey
HYPR|Hyperfine Inc|Price:0.970|Chg%:+0.016 - TradingKey
Hyperfine Inc (HYPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Hyperfine Inc (HYPR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Hyperfine Inc (HYPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hyperfine, Inc. (NASDAQ:HYPR) Receives Average Rating of "Hold" from Analysts - MarketBeat
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026 - Yahoo Finance
New Yale Study Shows Portable MRI Cuts Time to Brain Imaging by 80% in the Emergency Department - marketscreener.com
India Begins Using Hyperfine Swoop System for Bedside Brain Imaging - Medical Product Outsourcing
Peer-Reviewed Study Demonstrate Significant Economic and Operational Benefits of Portable MRI in Acute Hospital Care - marketscreener.com
Peer-Reviewte Studie belegt erhebliche wirtschaftliche und betriebliche Vorteile der mobilen MRT in Akutkrankenhäusern - Cision News
Enterprise value to EBITDA forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Price to earnings forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Enterprise value to EBIT forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Price to book forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Hyperfine Inc. (HYPR) Slides 4.89% as Stock Tests Key Support LevelsLow Beta Factor - dars.gov.et
Price to sales forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Hyperfine Inc. (HYPR) Slips 3.54% as Support Near $1.17 Faces Another TestHigh Conviction Picks - dars.gov.et
Hyperfine launches next-generation Swoop MRI system in Europe - Yahoo Finance
Hyperfine Inc. (HYPR) Remains Range-Bound Near Key Support LevelRevenue Growth Stocks - dars.gov.et
Hyperfine Launches Next-Gen Swoop MRI System in Europe (HYPR) - GuruFocus
Hyperfine Announces European Launch of Next-Generation Swoop® System - 01net
Lake Street Initiates Hyperfine(HYPR.US) With Buy Rating, Announces Target Price $2.5 - Moomoo
Hyperfine launches next-generation Swoop MRI system in Europe By Investing.com - Investing.com South Africa
Hyperfine, Inc.(NasdaqGM: HYPR) added to Russell 2000 Index - marketscreener.com
Hyperfine, Inc.(NasdaqGM: HYPR) added to Russell 2500 Growth Benchmark - marketscreener.com
Hyperfine, Inc.(NasdaqGM: HYPR) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Hyperfine, Inc.(NasdaqGM: HYPR) added to Russell 2000 Growth Benchmark - marketscreener.com
Hyperfine, Inc.(NasdaqGM: HYPR) added to Russell 3000E Growth Benchmark - marketscreener.com
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):